RAF1 and breast cancer: Although BA and BC KO did not reduce C-Raf-induced heightened proliferation in vitro, mice administered with either C-Raf AB KO or C-Raf BC KO cells exhibited drastically reduced metastatic burden compared to C-Raf overexpression only, as reflected in their survival (Figure 4E).